Avalo Therapeutics, Inc. (AVTX) - Latest Market Data

Price & Market Data

Price: $19.35

Daily Change: -$0.90 / 4.65%

Daily Range: $19.35 - $20.90

Market Cap: $1,041,383,424

Daily Volume: 1,708,740

Performance Metrics

1 Week: 22.63%

1 Month: 49.48%

3 Months: 36.48%

6 Months: 32.49%

1 Year: 398.5%

YTD: 9.80%

About Avalo Therapeutics, Inc. (AVTX)

Explore comprehensive market data for Avalo Therapeutics, Inc. (AVTX). Currently priced at 19.35, observe its daily movement of -$0.90 / 4.65%. The total market value is 1,041,383,424. Review its performance across various timeframes, including the last week, month, and year, to understand its trajectory.

Company Details

Employees: 33

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. Its lead asset includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.

Selected stocks

GCM Grosvenor Inc. (GCMG)

Clover Health Investments, Corp. (CLOV)

V.F. Corporation (VFC)

Sandisk Corporation (SNDK)